A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials